ProductsIsraeli Entrepreneurs’ Terpenes Plans For UK

Israeli Entrepreneurs’ Terpenes Plans For UK


TWO Israeli businessmen with strong UK links have joined forces to deliver high-quality cannabis terpenes to European consumers.

CiiTech, a leading cannabis business, has partnered with Kanabo Research to launch terpene formulas for use with the latter’s VapePod.

In a press release the partners say they will use CiiTech’s ‘terpene formulas to meet the highest standards required for the UK market’.

These have been designed specifically for use with the VapePod, Kanabo’s patented device which was the first to be approved for medical use by the Israeli Ministry of Health. 

Terpenes are essential plant oils that deliver distinctive flavors and smells and include the likes of linalool – also present in lavender –  and pinene, in conifers.

They also confer therapeutic effects, with cannabis terpenes being used to promote sleep, fight inflammation and boost mood.

CiiTech was was founded by Clifton Flack, once of  iCAN and the investment platform CannaTech. 

The London-based company initiates in-house research and created Provocan which has been selected as best in class among UK CBD brands.

He said trust in CBD brands is ‘crucial’ and collaboration with partners such as Kanabo can help achieve that.

He added: “There’s a real growth in consumer understanding of the terpenes. 

“We believe our proven formulas created with Kanabo for the VapePod device deliver an exceptional level of CBD innovation and efficacy not previously seen in the industry.”

Kanabo plans to list on the London Stock Exchange in what will be an effective reverse takeover with UK shell company Spinnaker Opportunities PLC.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you